Cargando…
Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
Aging contributes to the risk of development of ocular diseases including, but not limited to, Age-related Macular Degeneration (AMD) that is a leading cause of blindness in the United States as well as worldwide. Retinal aging, that contributes to AMD pathogenesis, is characterized by accumulation...
Autor principal: | Nashine, Sonali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464988/ https://www.ncbi.nlm.nih.gov/pubmed/34572131 http://dx.doi.org/10.3390/cells10092483 |
Ejemplares similares
-
Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)
por: Nashine, Sonali, et al.
Publicado: (2022) -
PU-91 drug rescues human age-related macular degeneration RPE cells; implications for AMD therapeutics
por: Nashine, Sonali, et al.
Publicado: (2019) -
Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
por: García-Onrubia, Luis, et al.
Publicado: (2020) -
Humanin G (HNG) protects age-related macular degeneration (AMD) transmitochondrial ARPE-19 cybrids from mitochondrial and cellular damage
por: Nashine, Sonali, et al.
Publicado: (2017) -
The role of lipocalin-2 in age-related macular degeneration (AMD)
por: Ghosh, Sayan, et al.
Publicado: (2020)